File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: phi and phiD predict adverse pathological features after radical prostatectomy for prostate cancer in Chinese population

Titlephi and phiD predict adverse pathological features after radical prostatectomy for prostate cancer in Chinese population
Authors
Keywordspathological outcomes
phi density
prostate cancer
Prostate Health Index
radical prostatectomy
Issue Date9-Aug-2024
PublisherWiley
Citation
Cancer Medicine, 2024, v. 13, n. 15 How to Cite?
AbstractBackground: Anticipating the postoperative pathological stage and potential for adverse features of prostate cancer (PCa) patients before radical prostatectomy (RP) is crucial for guiding perioperative treatment. Methods: A cohort consisting of three sub-cohorts with a total of 709 patients has been enlisted from two major tertiary medical centres in China. The primary assessment parameters for adverse pathological features in this study are the pathological T stage, the AJCC prognostic stage groups and perineural invasion (PNI). Logistic regression analyses were performed to investigate the relationship between prostate specific antigen (PSA), its derivatives (incluing Prostate Health Index, phi and phi density, phiD), and the pathological outcomes after RP. Results: Both phi and phiD showed a significant association with pathologic T stage of pT3 or above (phi, adjusted OR, AOR = 2.82, 95% confidence interval, 95% CI: 1.88–4.23, p < 0.001; phiD, AOR = 2.47, 95% CI: 1.76–3.48, p < 0.001) and PNI (phi, AOR = 2.15, 95% CI: 1.39–3.32, p < 0.001; phiD, AOR = 1.94, 95% CI: 1.38–2.73, p < 0.001). In a subgroup analysis with a total PSA value <10 ng/mL, phi and phiD continued to show a significant correlation with pT3 or above (phi, AOR = 4.70, 95% CI: 1.29–17.12, p = 0.019; phiD, AOR = 3.44, 95% CI: 1.51–7.85, p = 0.003), and phiD also maintained its predictive capability for PNI in this subgroup (AOR = 2.10, 95% CI: 1.17–3.80, p = 0.014). Sensitivity analysis indicated that the findings in the combined cohort are mainly influenced by one of the sub-cohorts, partially attributable to disparities in sample sizes between sub-cohorts. Combined analysis of phi(D) and multiparametric MRI (mpMRI) data yielded similar results. Conclusions: Preoperative measurement of serum phi and phiD is valuable for predicting the occurrence of adverse pathological features in Chinese PCa patients after RP.
Persistent Identifierhttp://hdl.handle.net/10722/357244
ISSN
2023 Impact Factor: 2.9
2023 SCImago Journal Rankings: 1.174
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorShi, Ruofan-
dc.contributor.authorHuang, Da-
dc.contributor.authorYan, Jiaqi-
dc.contributor.authorRuan, Xiaohao-
dc.contributor.authorHuang, Jingyi-
dc.contributor.authorLiu, Jiacheng-
dc.contributor.authorHuang, Jinlun-
dc.contributor.authorZhan, Yongle-
dc.contributor.authorYao, Chi-
dc.contributor.authorChun, Tsun Tsun Stacia-
dc.contributor.authorHo, Brian Sze‐Ho-
dc.contributor.authorNg, Ada Tsui‐Lin-
dc.contributor.authorGao, Yi-
dc.contributor.authorXu, Danfeng-
dc.contributor.authorNa, Rong-
dc.date.accessioned2025-06-23T08:54:16Z-
dc.date.available2025-06-23T08:54:16Z-
dc.date.issued2024-08-09-
dc.identifier.citationCancer Medicine, 2024, v. 13, n. 15-
dc.identifier.issn2045-7634-
dc.identifier.urihttp://hdl.handle.net/10722/357244-
dc.description.abstractBackground: Anticipating the postoperative pathological stage and potential for adverse features of prostate cancer (PCa) patients before radical prostatectomy (RP) is crucial for guiding perioperative treatment. Methods: A cohort consisting of three sub-cohorts with a total of 709 patients has been enlisted from two major tertiary medical centres in China. The primary assessment parameters for adverse pathological features in this study are the pathological T stage, the AJCC prognostic stage groups and perineural invasion (PNI). Logistic regression analyses were performed to investigate the relationship between prostate specific antigen (PSA), its derivatives (incluing Prostate Health Index, phi and phi density, phiD), and the pathological outcomes after RP. Results: Both phi and phiD showed a significant association with pathologic T stage of pT3 or above (phi, adjusted OR, AOR = 2.82, 95% confidence interval, 95% CI: 1.88–4.23, p < 0.001; phiD, AOR = 2.47, 95% CI: 1.76–3.48, p < 0.001) and PNI (phi, AOR = 2.15, 95% CI: 1.39–3.32, p < 0.001; phiD, AOR = 1.94, 95% CI: 1.38–2.73, p < 0.001). In a subgroup analysis with a total PSA value <10 ng/mL, phi and phiD continued to show a significant correlation with pT3 or above (phi, AOR = 4.70, 95% CI: 1.29–17.12, p = 0.019; phiD, AOR = 3.44, 95% CI: 1.51–7.85, p = 0.003), and phiD also maintained its predictive capability for PNI in this subgroup (AOR = 2.10, 95% CI: 1.17–3.80, p = 0.014). Sensitivity analysis indicated that the findings in the combined cohort are mainly influenced by one of the sub-cohorts, partially attributable to disparities in sample sizes between sub-cohorts. Combined analysis of phi(D) and multiparametric MRI (mpMRI) data yielded similar results. Conclusions: Preoperative measurement of serum phi and phiD is valuable for predicting the occurrence of adverse pathological features in Chinese PCa patients after RP.-
dc.languageeng-
dc.publisherWiley-
dc.relation.ispartofCancer Medicine-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectpathological outcomes-
dc.subjectphi density-
dc.subjectprostate cancer-
dc.subjectProstate Health Index-
dc.subjectradical prostatectomy-
dc.titlephi and phiD predict adverse pathological features after radical prostatectomy for prostate cancer in Chinese population-
dc.typeArticle-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1002/cam4.70085-
dc.identifier.pmid39119746-
dc.identifier.scopuseid_2-s2.0-85200988081-
dc.identifier.volume13-
dc.identifier.issue15-
dc.identifier.eissn2045-7634-
dc.identifier.isiWOS:001287442000001-
dc.identifier.issnl2045-7634-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats